Stéphanie Espiard, MD, PhD

Department of Endocrinology and Metabolism, CHU de Lille
Lille, France

Disclosure information not submitted.

Presentation(s):

• SAT-013 - LINC 6 Ad Hoc Analysis of New Osilodrostat Users: Improvements in Quality of Life in Patients with Cushing'S Syndrome

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT